Gsa Capital Partners LLP Puma Biotechnology, Inc. Transaction History

Gsa Capital Partners LLP

$1.43 Billion
Q2 2025

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$2.76 - $3.88 $25,196 - $35,420	-9,129 Reduced 8.41%	99,394 $294,000
Q4 2024 Feb 07, 2025	BUY	$2.42 - $3.39 $142,850 - $200,108	59,029 Added 119.26%	108,523 $331,000
Q3 2024 Nov 05, 2024	SELL	$2.25 - $4.03 $315,578 - $565,235	-140,257 Reduced 73.92%	49,494 $126,000
Q2 2024 Aug 15, 2024	BUY	$2.92 - $5.83 $6,324 - $12,627	2,166 Added 1.15%	189,751 $619,000
Q1 2024 May 03, 2024	SELL	$4.29 - $7.4 $320,686 - $553,164	-74,752 Reduced 28.49%	187,585 $994,000
Q4 2023 Feb 16, 2024	SELL	$2.23 - $4.49 $38,561 - $77,641	-17,292 Reduced 6.18%	262,337 $1.14 Million
Q3 2023 Nov 15, 2023	BUY	$2.63 - $4.09 $433,768 - $674,567	164,931 Added 143.8%	279,629 $735,000
Q2 2023 Aug 14, 2023	BUY	$2.6 - $3.58 $298,214 - $410,618	114,698 New	114,698 $404,000
Q4 2022 Feb 13, 2023	SELL	$2.12 - $5.08 $142,847 - $342,295	-67,381 Reduced 48.02%	72,940 $309,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $162,468 - $274,836	71,572 Added 104.11%	140,321 $333,000
Q2 2022 Aug 09, 2022	SELL	$1.64 - $3.3 $115,118 - $231,640	-70,194 Reduced 50.52%	68,749 $196,000
Q1 2022 May 11, 2022	BUY	$2.13 - $3.24 $295,948 - $450,175	138,943 New	138,943 $400,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $245,214 - $566,143	-86,040 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $471,757 - $668,145	71,155 Added 478.03%	86,040 $603,000
Q2 2021 Aug 05, 2021	BUY	$8.98 - $11.6 $133,667 - $172,666	14,885 New	14,885 $137,000
Q1 2020 May 12, 2020	SELL	$6.28 - $14.57 $525,548 - $1.22 Million	-83,686 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$6.5 - $10.73 $384,709 - $635,065	59,186 Added 241.58%	83,686 $732,000
Q3 2019 Nov 12, 2019	SELL	$8.75 - $12.85 $45,657 - $67,051	-5,218 Reduced 17.56%	24,500 $264,000
Q2 2019 Aug 06, 2019	BUY	$12.3 - $35.76 $286,380 - $832,600	23,283 Added 361.82%	29,718 $378,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $133,654 - $272,650	6,435 New	6,435 $250,000

Others Institutions Holding PBYI

# of Institutions

124

Shares Held

33.1M

Call Options Held

68.2K

Put Options Held

Acorn Capital Advisors, LLC New York, NY

4.13M
Shares

$20.1 Million
9.27% of portfolio
Vanguard Group Inc Valley Forge, PA

3.71M
Shares

$18.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$17.4 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

2.01M
Shares

$9.78 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.87M
Shares

$9.13 Million
0.01% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $222M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account